2017-2021 Molecular Diagnostics and NAT Market: Supplier Shares and Market Segment Forecasts by Country

December 2016 | | ID: MA0DB200212EN
Venture Planning Group

Abstracts

This report provides the following data:

• Geographic Coverage:
  -          France
  -          Germany
  -          Italy
  -          Japan
  -          Spain
  -          UK
  -          USA
• Five-year sales forecasts for:
  -          Infectious Diseases
  -          Cancer
  -          Forensic Testing
  -          Genetic Diseases
  -          Paternity Testing/HLA Typing, and other applications.

• Sales forecasts for HIV, Hepatitis (A, B, C), Parvovirus B19 and West Nile Virus.
• Sales and market shares for major suppliers of molecular diagnostics and NAT assays.

List of Tables

Table 1.  France: Molecular Diagnostics Market by Major Application
Table 2.  Germany: Molecular Diagnostics Market by Major Application
Table 3.  Italian: Molecular Diagnostics Market by Major Application
Table 4.  Japanese: Molecular Diagnostics Market by Major Application
Table 5.  Spain: Molecular Diagnostics Market by Major Application
Table 6.  UK: Molecular Diagnostics Market by Major Application
Table 7.  U.S.A.: Molecular Diagnostics Market by Major Application
Table 8.  France: Infectious Disease Blood Screening NAT Reagent Market by Assay
Table 9.  Germany: Infectious Disease Blood Screening NAT Reagent Market by Assay
Table 10.  Italian: Infectious Disease Blood Screening NAT Reagent Market by Assay
Table 11.  Japanese: Infectious Disease Blood Screening NAT Reagent Market by Assay
Table 12.  Spain: Infectious Disease Blood Screening NAT Reagent Market by Assay
Table 13  UK: Infectious Disease Blood Screening NAT Reagent Market by Assay
Table 14.  U. S.A.: Infectious Disease Blood Screening NAT Reagent Market by Assay
Table 15.  France: Molecular Diagnostics Market, Estimated Sales and Shares of Major Suppliers
Table 16.  Germany: Molecular Diagnostics Market, Estimated Sales and Shares of Major Suppliers
Table 17.  Italian: Molecular Diagnostics Market, Estimated Sales and Shares of Major Suppliers
Table 18.  Japanese: Molecular Diagnostics Market, Estimated Sales and Shares of Major Suppliers
Table 19.  Spain: Molecular Diagnostics Market, Estimated Sales and Shares of Major Suppliers
Table 20.  UK: Molecular Diagnostics Market, Estimated Sales and Shares of Major Suppliers
Table 21.  U.S.A.: Molecular Diagnostics Market, Estimated Sales and Shares of Major Suppliers
Table 22.  France: HIV/Hepatitis Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers
Table 23.  Germany: HIV/Hepatitis Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers
 Table 24.  Italian: HIV/Hepatitis Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers
Table 25.  Japanese: HIV/Hepatitis Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers
Table 26.  Spain: HIV/Hepatitis Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers
Table 27.  UK: HIV/Hepatitis Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers
Table 28.  U.S.A.: HIV/Hepatitis Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers
Table 29.  U.S.A.: West Nile Virus Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers

Contents

This report provides the following data:
Geographic Coverage:

• France
• Germany
• Italy
• Japan
• Spain
• UK
• USA

Five-year sales forecasts for:

• Infectious Diseases
• Cancer
• Forensic Testing
• Genetic Diseases
• Paternity Testing/HLA Typing, and other applications.

Sales forecasts for HIV, Hepatitis (A, B, C), Parvovirus B19 and West Nile Virus.
Sales and market shares for major suppliers of molecular diagnostics and NAT assays.

List Of Tables

LIST OF TABLES

Table 1. France: Molecular Diagnostics Market by Major Application
Table 2. Germany: Molecular Diagnostics Market by Major Application
Table 3. Italian: Molecular Diagnostics Market by Major Application
Table 4. Japanese: Molecular Diagnostics Market by Major Application
Table 5. Spain: Molecular Diagnostics Market by Major Application
Table 6. UK: Molecular Diagnostics Market by Major Application
Table 7. U.S.A.: Molecular Diagnostics Market by Major Application
Table 8. France: Infectious Disease Blood Screening NAT Reagent Market by Assay
Table 9. Germany: Infectious Disease Blood Screening NAT Reagent Market by Assay
Table 10. Italian: Infectious Disease Blood Screening NAT Reagent Market by Assay
Table 11. Japanese: Infectious Disease Blood Screening NAT Reagent Market by Assay
Table 12. Spain: Infectious Disease Blood Screening NAT Reagent Market by Assay
Table 13 UK: Infectious Disease Blood Screening NAT Reagent Market by Assay
Table 14. U. S.A.: Infectious Disease Blood Screening NAT Reagent Market by Assay
Table 15. France: Molecular Diagnostics Market, Estimated Sales and Shares of Major Suppliers
Table 16. Germany: Molecular Diagnostics Market, Estimated Sales and Shares of Major Suppliers
Table 17. Italian: Molecular Diagnostics Market, Estimated Sales and Shares of Major Suppliers
Table 18. Japanese: Molecular Diagnostics Market, Estimated Sales and Shares of Major Suppliers
Table 19. Spain: Molecular Diagnostics Market, Estimated Sales and Shares of Major Suppliers
Table 20. UK: Molecular Diagnostics Market, Estimated Sales and Shares of Major Suppliers
Table 21. U.S.A.: Molecular Diagnostics Market, Estimated Sales and Shares of Major Suppliers
Table 22. France: HIV/Hepatitis Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers
Table 23. Germany: HIV/Hepatitis Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers
Table 24. Italian: HIV/Hepatitis Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers
Table 25. Japanese: HIV/Hepatitis Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers
Table 26. Spain: HIV/Hepatitis Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers
Table 27. UK: HIV/Hepatitis Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers
Table 28. U.S.A.: HIV/Hepatitis Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers
Table 29. U.S.A.: West Nile Virus Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers